POSB197 Impact of Immune Checkpoint Inhibitors (ICIS) on the Management of Advanced Non-Small Cell Lung Cancer (NSCLC) in Real-World Practice at Karolinska University Hospital, Stockholm between 2012 and 2018

Autor: S Ekman, OT Brustugun, JB Sørensen, AM Kejs, Q Ann, M Bortolini, A Calleja, L Rosengren, P Huetson, MJ Daumont, JR Penrod, HC Jacobs, L Lacoin, H Koyi

Publikováno v: Value in Health. 25:S132-S133

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9eefce2a2dddfd4e4313503def25a8ca
https://doi.org/10.1016/j.jval.2021.11.635

POSA327 Development of Conceptual Models Investigating the Health-Related Quality of Life (HRQOL) Impacts of Malignant Pleural Mesothelioma (MPM)

Autor: A Gibson, K Shah, W Ahmed, I Flint, L Longworth, B Bennett, M McKenna, MJ Daumont

Publikováno v: Value in Health. 25:S213

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4fc40fa38965711ba94e3588fcdbe57c
https://doi.org/10.1016/j.jval.2021.11.1038

Real-World Treatment Patterns and Survival Outcomes for Patients with Non-Metastatic Non-Small-Cell Lung Cancer in Sweden: A Nationwide Registry Analysis from the I-O Optimise Initiative.

Autor: Oskarsdottir GN; Department of Respiratory Medicine and Allergology, Skåne University Hospital, V/O Hjärt- och Lungmedicin, 222 42 Lund, Sweden.; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, 22 381 Lund, Sweden., Lampa E; Epistat AB, 753 30 Uppsala, Sweden., Berglund A; Epistat AB, 753 30 Uppsala, Sweden., Rosengren L; Medical Department Sweden, Bristol Myers Squibb, Hemvärnsgatan 9, 171 23 Solna, Sweden., Ulvestad M; Medical Department Nordics, Bristol Myers Squibb, Lysaker Torg 35, 1366 Lysaker, Norway., Boros M; Department of Cardiothoracic Surgery, Linköping University Hospital, 581 85 Linköping, Sweden., Daumont MJ; Worldwide Health Economics & Outcomes Research, Bristol Myers Squibb, 1420 Braine-L'Alleud, Belgium., Rault C; Data Gnosis, 35200 Rennes, France., Emanuel G; Real-World Data Analytics Markets, Bristol Myers Squibb, Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, UK., Leal C; IQVIA, 2740-265 Porto Salvo, Portugal., Schoemaker MJ; IQVIA, 1101 CT Amsterdam, The Netherlands., Wagenius G; Department of Oncology-Pathology, Karolinska Institute, 141 86 Stockholm, Sweden.; Thoracic Oncology Centre, The Cancer Theme, Karolinska University Hospital, 171 76 Stockholm, Sweden.

Publikováno v: Cancers [Cancers (Basel)] 2024 Apr 25; Vol. 16 (9). Date of Electronic Publication: 2024 Apr 25.

Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study.

Autor: Provencio M; Department of Medical Oncology, Puerta de Hierro Majadahonda University Hospital, Madrid, Spain., Carcereny E; Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona Badalona-Applied Research Group in Oncology (B-ARGO), Barcelona, Spain., López Castro R; Oncology Department, Valladolid University Clinical Hospital, Valladolid, Spain., Calvo V; Department of Medical Oncology, Puerta de Hierro Majadahonda University Hospital, Madrid, Spain., Rodríguez Abreu D; Thoracic, Skin Tumors & Clinical Trials Unit, Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Cobo M; Department of Medical Oncology, Málaga General University Hospital and Virgen de la Victoria, IBIMA, Málaga, Spain., Ortega AL; Medical Oncology Service, Jaen University Hospital, Jaen, Spain., Bernabé R; Thoracic Oncology Cancer Unit, Virgen del Rocío University Hospital, Seville, Spain., Guirado M; Department of Medical Oncology, Elche University General Hospital, Elche, Spain., Massutí B; Department of Medical Oncology, Alicante University General Hospital, Alicante, Spain., Del Barco-Morillo E; Department of Medical Oncology, Salamanca University Hospital, Salamanca, Spain., Bosch-Barrera J; Catalan Institute of Oncology, University Hospital Dr. Josep Trueta, Girona, Spain., Camps C; Molecular Oncology Laboratory, Valencia University General Hospital, Valencia, Spain., Carroll R; Bristol Myers Squibb, Centre for Observational Research and Data Sciences, Uxbridge, UK., Rault C; Data Gnosis, Rennes, France., Chaib C; Bristol Myers Squibb, Madrid, Spain., Penrod J; Bristol Myers Squibb, Princeton, NJ, USA., Vo L; Bristol Myers Squibb, Princeton, NJ, USA., Ralphs E; IQVIA, London, UK., Daumont MJ; Bristol Myers Squibb, Braine-l'Alleud, Belgium.

Publikováno v: Translational lung cancer research [Transl Lung Cancer Res] 2023 Oct 31; Vol. 12 (10), pp. 2113-2128. Date of Electronic Publication: 2023 Oct 27.

Evolution of treatment patterns and survival outcomes in patients with advanced non-small cell lung cancer treated at Frankfurt University Hospital in 2012-2018.

Autor: Wolf A; University Cancer Center, University Hospital Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany. andreayvonne.wolf@kgu.de., Stratmann JA; Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt am Main, Germany., Shaid S; Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt am Main, Germany., Niklas N; Real World Solutions, IQVIA, Frankfurt, Germany., Calleja A; Real World Solutions, IQVIA, London, UK., Ubhi H; Real World Solutions, IQVIA, London, UK., Munro R; Real World Solutions, IQVIA, London, UK., Waldenberger D; Medical Oncology, Bristol Myers Squibb GmbH & Co. KGaA, Munich, Germany., Carroll R; Centre for Observational Research and Data Sciences, Bristol Myers Squibb, Uxbridge, UK., Daumont MJ; Worldwide Health Economics and Outcomes Research, Bristol Myers Squibb, Braine-l'Alleud, Belgium., Penrod JR; Worldwide Health Economics and Outcomes Research, Bristol Myers Squibb, Princeton, NJ, USA., Lacoin L; Epi-Fit, Bordeaux, France., Rohde G; Medical Clinic I, Department of Respiratory Medicine, University Hospital Frankfurt, Frankfurt am Main, Germany.

Publikováno v: BMC pulmonary medicine [BMC Pulm Med] 2023 Jan 13; Vol. 23 (1), pp. 16. Date of Electronic Publication: 2023 Jan 13.